Raymond Miralbell

Medical director at Centro de Protonterapia of Quirónsalud, Madrid, Spain, since 2019. Chairman of Servei de Radiooncologia at Institut Oncologic Teknon of Quironsalud, Barcelona, Spain. Chairman and Associated Professor of the Radiation Oncology Division, at the University Hospitals of Geneva (Switzerland) 2006-2019. Chairman of the Swiss Proton Users Group 2000- 2008. Radiation oncologist trained from 1979 through 1989 in the University of Barcelona and the University of Harvard. Main research domain: Prostate cancer, breast cancer, proton therapy. - Imaging for radiotherapy treatment planning Treatment precision optimization through image guided radiotherapy Tracing of the biochemical relapse after curative surgery or radiotherapy- Prognostic value of hypoxic markers (pathological and imaging)- Quality of life studies in fragile patients on androgen deprivation - Biological modeling of prostate cancer response to irradiation and fractionation sensitivity. - Biological modeling for salvage radiotherapy after post-irradiation local failure - Stereo-tactic beam radiotherapy for prostate, gynecologic, ocular/orbital, and oligometastatic tumors.